Back

Distinct evolutionary patterns of tumor immune escape and elimination determined by ECM architectures

Fan, Y.; George, J. T.

2024-05-15 biophysics
10.1101/2024.05.13.594017 bioRxiv
Show abstract

Cancer progression remains a significant clinical challenge. Phenotypic adaptation by tumor cells results in disease hetero-geneity, which drives treatment resistance and immune escape. T cell immunotherapy, while effective at treating some cancer subtypes, can also fail due to limits on tumor immunogenicity or T cell recognition. For example, one potential contributor to immune escape involves the density and alignment of the extracellular matrix (ECM) surrounding tumors, also known as Tumor-Associated Collagen Signature (TACS). However, the specific mechanisms by which aligned fibers contribute to decreased patient survival rates have not yet been decoupled. Here, we developed our EVO-ACT (EVOlutionary Agent-based Cancer T cell interaction) model to study how TACS affects tumor evolution and dynamic tumor-T cell interactions. We identified a variety of TACS-specific dynamical features that influence T cell infiltration, cancer immunoediting, and ultimate immune escape. Our model demonstrates how TACS and phenotypic adaptation together explain overall survival trends in breast cancer.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.